Stonepine Capital Management, LLC
- SEC CIK
- 0001440771
- Latest filing
- Aug 17, 2026
ADMA holding history
Adma Biologics, Inc. in every 13F filed by Stonepine Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings
- Shares (Q2 2026)
- 740,000
- Value
- $6.19M
- % of portfolio
- 4.7%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 740,000 | $6.19M | 4.7% | 00.0% | Unchanged | Holders |
| Q1 2026 | 740,000 | $6.67M | 5.9% | 00.0% | Unchanged | Holders |
| Q4 2025 | 740,000 | $13.5M | 10.7% | +1,000+0.1% | Added | Holders |
| Q3 2025 | 739,000 | $10.8M | 8.8% | −11,000−1.5% | Reduced | Holders |
| Q2 2025 | 750,000 | $13.7M | 13.5% | −60,000−7.4% | Reduced | Holders |
| Q1 2025 | 810,000 | $24.3K | <0.1% | −431,032−34.7% | Reduced | Holders |
| Q4 2024 | 1,241,032 | $21.3M | 17.2% | −628,968−33.6% | Reduced | Holders |
| Q3 2024 | 1,870,000 | $37.4M | 23.6% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,870,000 | $20.9M | 19.1% | −1,556,882−45.4% | Reduced | Holders |
| Q1 2024 | 3,426,882 | $22.6M | 17.9% | −5,795,735−62.8% | Reduced | Holders |
| Q4 2023 | 9,222,617 | $41.7M | 18.0% | +118,342+1.3% | Added | Holders |
| Q3 2023 | 9,104,275 | $32.6M | 10.8% | +310,954+3.5% | Added | Holders |
| Q2 2023 | 8,793,321 | $32.4M | 11.7% | +1,131,631+14.8% | Added | Holders |
| Q1 2023 | 7,661,690 | $25.4M | 8.5% | +721,690+10.4% | Added | Holders |
| Q4 2022 | 6,940,000 | $26.9M | 11.3% | +1,940,000+38.8% | Added | Holders |
| Q3 2022 | 5,000,000 | $12.2M | 5.5% | −2,000,000−28.6% | Reduced | Holders |
| Q2 2022 | 7,000,000 | $13.9M | 6.4% | −131,808−1.8% | Reduced | Holders |
| Q1 2022 | 7,131,808 | $13.1M | 5.4% | −2,779,769−28.0% | Reduced | Holders |
| Q4 2021 | 9,911,577 | $14.0M | 6.4% | +9,911,577 | New | Holders |